|
|
|
|
|
|
|
|
Blogger's Note: study included major ovarian cancer cell types/LMP
open access
PALB2 c.2323C>T [p.Q775X]
Conclusion
The PALB2 c.2323C>T [p. Q775X] mutation confers increased risk for breast cancer in the French
Canadian population of Quebec. The contribution of PALB2 c.2323C>T [p. Q775X] to the causation of breast cancer in French-Canadians appears
to be lesser than that attributable to the most common founder alleles in BRCA1 and BRCA2, but the young age at diagnoses and associated familial history of breast cancer
suggest that this variant should be added to the panel of deleterious mutations screened
for assessing breast cancer risk in this unique population. Indeed during the preparation
of this manuscript another PALB2 carrier harboring the p.Q775X variant was identified in the Hereditary Cancer Clinics
affiliated with McGill University Health Centre. The carrier had bilateral breast
cancer at ages 34 and 42 years and a strong family history of breast cancer further
supporting the notion that PALB2 p.Q775X carriers are at increased risk for breast cancer.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.